Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Athenex logo — company profile

Athenex

Founded 2003 United States Buffalo, United States 89 employees Post Ipo Equity Total: $342.15M Biotechnology, Pharmaceutical

General Information

Company Name Athenex
Founded Year 2003
Location United States Buffalo, United States +1
Employees 89
Industries Biotechnology, Pharmaceutical
Funding Stage Post Ipo Equity
Social

Get notified when Athenex moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Athenex

Athenex is a global specialty oncology pharmaceutical company founded in 2003 and headquartered in the United States. The company is dedicated to the development and commercialization of next generation therapies for cancer diseases and supportive therapies. With a focus on delivering innovative drugs that can have a life-changing impact on cancer patients, Athenex operates medical technology innovation centers and a unique manufacturing supply chain across both China and North America. Through its connected innovation and manufacturing supply chain presence, Athenex can identify, develop, and deliver proprietary medical technology across continents and multiple regulatory environments. The company's last investment of $30.00MPost-IPO Equity was made on 11 August 2022, marking a significant milestone in its growth. Although the specific investors for this round are not disclosed, it underscores confidence in Athenex's potential within the biotechnology and pharmaceutical industries.

Taxonomy: oncology pharmaceutical, cancer therapies, innovation, manufacturing supply chain, global, specialty pharmaceuticals, drug development, life-changing impact, China, North America, proprietary medical technology, regulatory environments, connected innovation, global presence

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 11 Aug 2022
Post-IPO Equity •••••• 1
Investor
05 Dec 2019
Post-IPO Equity •••••• 2
Investor Investor
06 May 2019
Post-IPO Equity •••••• 1
Investor
02 Jul 2018
Private Equity Round •••••• 1
Investor
20 May 2015

View All 10 Funding Rounds

Athenex Alternatives & Competitors

Athenex vs
Vineti
Vineti United States

Vineti’s Personalized Therapy Management (PTM®) drives and scales advanced therapies

Series C
20 employees
Biotechnology, Computing
Compare Athenex vs Vineti
Athenex vs
Anticancer Bioscience
Anticancer Bioscience China

Applying our synthetic lethality expertise for better cancer therapies

Seed
17 employees
Biotechnology, Health Care
Compare Athenex vs Anticancer Bioscience
Athenex vs
SCG Cell Therapy
SCG Cell Therapy Singapore

Leading the Next Wave of Biotech Breakthroughs

Series C
24 employees
Biotechnology, Life Sciences
Compare Athenex vs SCG Cell Therapy

FAQ About Athenex

Athenex is a global specialty oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies. The company is dedicated to delivering innovative drugs that can have a life-changing impact on cancer patients...
Athenex was founded in 2003.
Athenex is headquartered in Buffalo, United States.
Athenex operates in the following industries: Biotechnology, Pharmaceutical.
Athenex has approximately 89 employees.
Athenex has completed 10 funding rounds, raising a total of $342.15M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Athenex include Vineti, Anticancer Bioscience, SCG Cell Therapy, 海杰亚(北京)医疗器械有限公司, MedTherapy Biotech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Athenex and Vineti are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Athenex and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy